PSYB:CC News and Press, Psybio Therapeutics Corp. From 08/08/22

PsyBio Therapeutics Announces Expansion of Patent Portfolio with Additional Global Patent Applications Canada NewsWire PsyBio is continuing to increase its psycho-targeted patent portfolio, executing on its strategic priorities of innovation, development, and technolog...

PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual and Special Meeting of Shareholders Canada NewsWire OXFORD, Ohio and DENVER , June 27, 2022 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (" PsyBio " or...

PsyBio Therapeutics Initiates Commercial Biosynthetic Based Process Development for Psycho-Targeted and Psychoactive Compounds Canada NewsWire PsyBio Therapeutics Advances Proprietary Patent Pending Manufacturing Towards Fully Developed GMP Production Methodology ...

PsyBio Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update on Intellectual Property and Clinical Development Milestones Canada NewsWire OXFORD, OH and DENVER, CO , May 30, 2022 /CNW/ - PsyBio Therapeutics Corp. (TSX...

PsyBio Therapeutics Develops Commercial Purification Process for Second Generation Psycho-Targeted Compound Canada NewsWire PsyBio Therapeutics Further Expands Scalable Manufacturing Process Development OXFORD, Ohio and COCONUT CREEK, Fla. , May 1...

Vancouver, Kelowna, Delta, BC - May 13, 2022 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Green Automotive, Cannabis, Psychedelics, Real Estate and Sports. Today's stocks have been...

PsyBio Therapeutics Initiates Blood-Brain Barrier Permeability Testing for Pipeline Compounds to Enhance Portfolio Development Canada NewsWire PsyBio Therapeutics Further Expands Testing of Portfolio Compounds OXFORD, Ohio and COCONUT CREEK, Fla. , ...

NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27 th and 28 th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing....

PsyBio Therapeutics Begins Filing Global Provisional Patent Conversion Applications to Further Strengthen Biosynthetic Patent Portfolio Canada NewsWire PsyBio Therapeutics further extends and expands intellectual property protection OXFORD, Ohio and C...

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences , the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Co...